8:13 AM ET
8-K
Loan & Debt
Akebia Therapeutics $140M Debt Financing with Symbiotic Capital Opportunities Holding, L.P.
Akebia Therapeutics entered into a $140 million senior secured term loan facility with Symbiotic Capital, consisting of a $60 million initial tranche and $80 million in discretionary tranches. The company used the initial proceeds to repay its existing $55 million debt facility with BlackRock (Kreos). The new facility features a 60-month interest-only period with a maturity date of November 12, 2031.
- Value
- $140M
- Counterparty
- Symbiotic Capital Opportunities Holding, L.P.
- Term
- 5 years